Dr. Mysore Vijayendra Maitri, MD

Dr. Maitri practices at Inova Medical Group Ashburn Healthplex - HOPD in Ashburn, Virginia.

Dr. Maitri's NPI, 1073697082, was assigned on October 25, 2006. Dr. Maitri holds Virginia license 0101250502.

Dr. Maitri's primary practice is Inova Medical Group Ashburn Healthplex - HOPD, at 22505 Landmark CT, Ashburn, VA 20148.

Dr. Maitri's primary practice is Inova Medical Group Ashburn Healthplex - HOPD in Ashburn, Virginia. Dr. Maitri is also affiliated with Inova Fairfax Hospital. The medical group on file is Inova Urgent Care Center. Dmand AI also links Dr. Maitri to 1 more hospital, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account. Dr. Maitri's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Maitri practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Maitri's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Maitri is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Maitri's licenses on file in 2 states: Virginia and New York.

CMS data shows 335 Medicare services from Dr. Maitri across 5 procedure codes in 2024, for 104 Medicare patients. Medicare paid $28,140 for them. Every service was in an office.

CMS counts 104 Medicare patients who saw Dr. Maitri in 2024. The largest group is 65 to 74, with 56 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.08, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Maitri's median patient age at 52, with 77% women.

In 2024, Dr. Maitri wrote 2,267 Medicare Part D claims for 171 patients. 92% of them were for generic drugs. CMS names the drug for 1,783 of them, across 50 drugs with 11 or more claims each, at $103,811 in total drug cost. In 2023, CMS named 1,532 claims across 42 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Maitri for performance year 2024, reported through an alternative payment model (APM). Dr. Maitri accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Maitri as offering telehealth.

CMS Open Payments shows 5 general payments to Dr. Maitri from 5 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $123.